11. Obesity (1) - insulin resistance Flashcards
Difference between peripheral and central obesity
Peripheral
- subcutaneous fat
- excess below the waist (hips, butt, thighs)
- NOT likely a major health risk factor
Central (Abdominal) Obesity
- visceral fat (surrounds heart, liver, intestines, kidney)
- very strong predictor of health risk
- pro-inflammatory, IR, diabetes risk, heart disease
Easiest way to measure Visceral Fat
- male and female measure
- other ways to measure
waist circumference
- men > 102 cm
- women > 88 cm
others
- MRI and CT
- $$$
key independent predictor of all cause mortality
- some basic measurements
visceral fat
- 0.5kg normal
- 1.0kg 2 fold higher risk for mortality
Why is increased visceral fat a potential health risk?
associated with
- increased lipolysis
- increased plasma FFAs
- increased secretory products (adipokines -> inflammatory mediator)
- *increased insulin resistance**
- less glucose uptake into cells
- increased blood glucose levels
what do adipokines do?
inflammatory mediator
adipo = fat kines = signal molecules
what is insulin resistance?
- how does it impair normal response
- result in skeletal muscle
inability of insulin to produce a “normal” response at a given tissue
- defect in insulin signalling leads to impaired GLUT4 translocation to membrane
- reduced insulin stimulated glucose uptake in muscle
hyperinsulinemia definition
- high levels of insulin in the blood
- result from over production of insulin in the pancreas in order to compensate for insulin resistance
stages in the development of T2D
- is it reversible?
1) impaired glucose tolerance
- obesity causes insulin resistance and impaired glucose tolerance directly
- hyperinsulinemia -> over production of insulin to compensate for resistance
2) early diabetes
- decreased insulin secretion
- result from beta cell defect
- cells exhausted and damaged from overproduction
3) late diabetes
- beta cells fail
- no insulin produced
** can be reversible with lifestyle change depending on stage -> only lived with it for a few years
clinal signs of T2D
Glucose
- fasting hyperglycemia (>7mM)
Insulin
- dependent on stage of diabetes
- impaired gluc tolerance -> high levels
- early diabetes -> low levels
- late diabetes -> no insulin
clinical tests used to assess diabetes
1) oral glucose tolerance test
2) euglycemic / hyperinsulinemic clamp
diabetes NOT associated with diabetes
Type 1 diabetes
(aka juvenile or insulin-dependent diabetes)
- autoimmune disease
- children
- genetics or exposure to certain virusis
- no cure (irreversible)
OGTT
Oral Glucose Tolerance Test
- measures acute metabolic response to glucose ingestion at whole body level
Method
- 75g glucose beverage (Trutol)
- measured 2hrs after ingestion (should return to near normal levels)
OGTT clinical diagnostic measurements
Diagnostic criteria after 2hrs from ingestion
- 7.8mM = impaired glucose tolerance
- 11.1mM = T2D
OGTT response to “glucose” in lean, obese and T2D
Normal
- fasting ~4-5mM
- peak at 1hr ~6-7mM
- return to normal after 2hr
- obese without diabetes similar response*
T2D
- impaired fasting glucose ~6-7mM
- huge spike glucose response (peak at 1hr)
- diagnosed with disease at 11.1mM after 2hr
- > 3hrs to return to normal
OGTT response to “insulin” in lean, obese and T2D
Fasting insulin - similar for all health states (~10mM but highly variable between individuals)
Lean (healthy)
- peak after 30min ~40mM
- slow/steady decline
Obese (healthy)
- “huge”peak after 30min ~90mM (hyperinsulinemia)
- indicates insulin resistance
- pancreas works hard not to become diabetic
Obese T2D
- peak after 1.5hr* (much longer)
- peak response between obese and lean ~50-60mM
- pancreas exhausted, fewer cells to secrete amount needed
Lean T2D
- little to no response
- similar to type 1
- pancreas likely severely damaged
Euglycemic definition
normal blood glucose level
Gold standard for measuring whole body insulin sensitivity
hyperinsulinemia euglycemic clamp
- measures responsiveness to insulin
- used in lab, not clinically ($$$)